Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1886 1
1929 1
1947 1
1948 2
1949 2
1950 10
1951 1
1952 9
1953 5
1954 6
1955 10
1956 11
1957 18
1958 19
1959 6
1960 16
1961 20
1962 15
1963 23
1964 9
1965 4
1966 18
1967 19
1968 29
1969 30
1970 21
1971 33
1972 28
1973 23
1974 20
1975 19
1976 20
1977 8
1978 13
1979 11
1980 10
1981 12
1982 11
1983 11
1984 18
1985 13
1986 12
1987 13
1988 10
1989 15
1990 18
1991 24
1992 18
1993 16
1994 18
1995 17
1996 16
1997 14
1998 11
1999 11
2000 13
2001 15
2002 17
2003 20
2004 22
2005 13
2006 19
2007 21
2008 35
2009 41
2010 36
2011 51
2012 60
2013 37
2014 43
2015 37
2016 48
2017 53
2018 60
2019 53
2020 48
2021 62
2022 45
2023 56
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

1,576 results

Results by year

Filters applied: . Clear all
Page 1
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Morand E, Pike M, Merrill JT, van Vollenhoven R, Werth VP, Hobar C, Delev N, Shah V, Sharkey B, Wegman T, Catlett I, Banerjee S, Singhal S. Morand E, et al. Among authors: merrill jt. Arthritis Rheumatol. 2023 Feb;75(2):242-252. doi: 10.1002/art.42391. Epub 2022 Nov 11. Arthritis Rheumatol. 2023. PMID: 36369798 Free PMC article. Clinical Trial.
Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
Urowitz MB, Aranow C, Asukai Y, Bass DL, Bruce IN, Chauhan D, Dall'Era M, Furie R, Fox NL, Gilbride JA, Hammer A, Ginzler EM, Gonzalez-Rivera T, Levy RA, Merrill JT, Quasny H, Roth DA, Stohl W, van Vollenhoven R, Wallace DJ, Petri M. Urowitz MB, et al. Among authors: merrill jt. Arthritis Care Res (Hoboken). 2022 Nov;74(11):1822-1828. doi: 10.1002/acr.24901. Epub 2022 Aug 4. Arthritis Care Res (Hoboken). 2022. PMID: 35439360 Free PMC article. Review.
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS. Petri M, et al. Among authors: merrill jt. Arthritis Rheum. 2012 Aug;64(8):2677-86. doi: 10.1002/art.34473. Arthritis Rheum. 2012. PMID: 22553077 Free PMC article.
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials.
Vital EM, Merrill JT, Morand EF, Furie RA, Bruce IN, Tanaka Y, Manzi S, Kalunian KC, Kalyani RN, Streicher K, Abreu G, Tummala R. Vital EM, et al. Among authors: merrill jt. Ann Rheum Dis. 2022 Jul;81(7):951-961. doi: 10.1136/annrheumdis-2021-221425. Epub 2022 Mar 25. Ann Rheum Dis. 2022. PMID: 35338035 Free PMC article. Clinical Trial.
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.
Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE. Buyon JP, et al. Among authors: merrill jt. Ann Intern Med. 2015 Aug 4;163(3):153-63. doi: 10.7326/M14-2235. Ann Intern Med. 2015. PMID: 26098843 Free PMC article.
Reply.
Merrill JT. Merrill JT. Arthritis Rheumatol. 2022 Jun;74(6):1093. doi: 10.1002/art.42096. Epub 2022 Apr 19. Arthritis Rheumatol. 2022. PMID: 35188717 No abstract available.
Addiction disorders.
Merrill JO, Duncan MH. Merrill JO, et al. Med Clin North Am. 2014 Sep;98(5):1097-122. doi: 10.1016/j.mcna.2014.06.008. Med Clin North Am. 2014. PMID: 25134875 Review.
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Choi MY, Chen I, Clarke AE, Fritzler MJ, Buhler KA, Urowitz M, Hanly J, St-Pierre Y, Gordon C, Bae SC, Romero-Diaz J, Sanchez-Guerrero J, Bernatsky S, Wallace DJ, Isenberg DA, Rahman A, Merrill JT, Fortin PR, Gladman DD, Bruce IN, Petri M, Ginzler EM, Dooley MA, Ramsey-Goldman R, Manzi S, Jönsen A, Alarcón GS, van Vollenhoven RF, Aranow C, Mackay M, Ruiz-Irastorza G, Lim S, Inanc M, Kalunian K, Jacobsen S, Peschken C, Kamen DL, Askanase A, Buyon JP, Sontag D, Costenbader KH. Choi MY, et al. Among authors: merrill jt. Ann Rheum Dis. 2023 Jul;82(7):927-936. doi: 10.1136/ard-2022-223808. Epub 2023 Apr 21. Ann Rheum Dis. 2023. PMID: 37085289
1,576 results